Aushon BioSystems is a biotechnology startup founded in 2003, specializing in comprehensive protein biomarker assay development, detection, and analysis. The company offers a pioneering, cost-efficient multiplex immunoassay platform with over 300 biomarkers in critical therapeutic areas and advanced microarray printing technology. Their suite of products and services targets top-tier entities in the pharmaceutical, biotechnology, academic, and diagnostic sectors, providing a unique and complete solution for clients. Aushon BioSystems prides itself on delivering outstanding performance, quality, and reliability to accelerate pre-clinical and clinical biomarker research. The startup received a $3.65M Venture Round investment on 28 July 2016, indicating a strong interest from investors in their innovative approach to protein biomarker data. This investment is poised to enhance their research productivity and reduce costs, making them a potential prospect for venture capital firms seeking opportunities in the biotechnology and pharmaceutical industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $3.65M | - | 28 Jul 2016 | |
| Venture Round | $8.01M | 1 |
|
26 Nov 2014 |
| Venture Round | $5.50M | - | 24 Sep 2012 | |
| Venture Round | $2.00M | - | 21 Dec 2011 | |
| Venture Round | $6.50M | 1 | North Bridge Venture Partners & Growth Equity | 30 Mar 2009 |
No recent news or press coverage available for Aushon BioSystems.
We care about your data, and we'd love to use cookies make your experience better.
